Dashboard
1
High Management Efficiency with a high ROCE of 11.12%
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 11.47%
4
Flat results in Jun 25
5
With ROCE of 12.70%, it has a attractive valuation with a 1.73 Enterprise value to Capital Employed
6
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.39%
0%
2.39%
6 Months
41.58%
0%
41.58%
1 Year
56.19%
0%
56.19%
2 Years
80.22%
0%
80.22%
3 Years
178.36%
0%
178.36%
4 Years
85.66%
0%
85.66%
5 Years
136.25%
0%
136.25%
Genky DrugStores Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

Genky DrugStores Upgraded to 'Hold' Amid Mixed Technical Indicators and Stable Growth
Genky DrugStores Co., Ltd. has transitioned from a 'Not Rated' status to a 'Hold' designation by MarketsMOJO, reflecting changes in its technical score. The company shows stable growth with an annual net sales increase of 11.47% and a strong return on capital employed, despite a significant debt load.
Read More Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.47%
EBIT Growth (5y)
21.05%
EBIT to Interest (avg)
91.46
Debt to EBITDA (avg)
2.12
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
2.32
Tax Ratio
28.18%
Dividend Payout Ratio
5.59%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.12%
ROE (avg)
13.52%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.05
EV to EBIT
13.63
EV to EBITDA
8.28
EV to Capital Employed
1.73
EV to Sales
0.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.70%
ROE (Latest)
13.57%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'24 - YoY
Mar'24
Mar'23
Change(%)
Net Sales
44,620.00
40,331.00
10.63%
Operating Profit (PBDIT) excl Other Income
3,517.00
2,624.00
34.03%
Interest
26.00
9.00
188.89%
Exceptional Items
-164.00
0.00
Consolidate Net Profit
1,369.00
1,042.00
31.38%
Operating Profit Margin (Excl OI)
47.20%
34.50%
1.27%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2024 is 10.63% vs 7.48% in Mar 2023
Consolidated Net Profit
YoY Growth in quarter ended Mar 2024 is 31.38% vs 11.66% in Mar 2023
Annual Results Snapshot (Consolidated) - Jun'23
Jun'23
Jun'22
Change(%)
Net Sales
169,059.00
154,639.60
9.32%
Operating Profit (PBDIT) excl Other Income
11,665.00
10,267.10
13.62%
Interest
70.00
59.10
18.44%
Exceptional Items
-420.00
-1.80
-23,233.33%
Consolidate Net Profit
4,764.00
4,420.70
7.77%
Operating Profit Margin (Excl OI)
39.70%
36.70%
0.30%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2023 is 9.32% vs 8.61% in Jun 2022
Consolidated Net Profit
YoY Growth in year ended Jun 2023 is 7.77% vs -8.51% in Jun 2022
About Genky DrugStores Co., Ltd. 
Genky DrugStores Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






